Literature DB >> 26846424

Socioeconomic and clinical factors explaining the risk of unstructured antiretroviral therapy interruptions among Kenyan adult patients.

Edwin Mûnene1, Björn Ekman2.   

Abstract

A cross-sectional study was conducted to assess the extent of unstructured HIV treatment interruptions (TIs) and investigate the effects of socioeconomic, socio-demographic, HIV treatment-related and clinical factors on the magnitude and rate of the same among adult patients at a Kenyan regional referral center. Four hundred and twenty-one adult patients actively receiving antiretroviral therapy at Nyeri County Referral Hospital since 2003 were randomly selected to complete a health survey questionnaire. Electronic records were used to obtain their HIV treatment utilization history. The marginal effects of selected determinants on prevalence and rate of TI were assessed by fitting multiple Poisson log-linear regression models. In total, 392 patients participated in the study. HIV TI was prevalent with 64.5% having had at least one TI of 3 months or more during treatment. The risk of TI was significantly higher in those longer on treatment (prevalence ratio = 1.2, 95% confidence interval [CI] 1.12-1.28). Greater risk of TI was also associated with lower income (prevalence rate ratio [PRR] = 0.9, 95% CI 0.83-1.00), low medication adherence (PRR = 0.3, 95% CI 0.13-0.72), inconsistent treatment engagement (PRR = 0.4, 95% CI 0.19-0.75) and, contrarily, fewer adverse drug reactions (PRR = 0.9, 95% CI 0.90-0.97). Unstructured HIV TIs appear to be fairly common at the study site. The results suggest that efforts to minimize HIV TI could benefit from treatment-continuity monitoring strategies that target the high-risk sub-samples identified.

Entities:  

Keywords:  Kenya; Unstructured HIV treatment interruption; risk factors; sub-Saharan Africa

Mesh:

Substances:

Year:  2016        PMID: 26846424     DOI: 10.1080/09540121.2016.1140890

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  3 in total

1.  Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study.

Authors:  Andrew N Phillips; Valentina Cambiano; Fumiyo Nakagawa; Paul Revill; Michael R Jordan; Timothy B Hallett; Meg Doherty; Andrea De Luca; Jens D Lundgren; Mutsa Mhangara; Tsitsi Apollo; John Mellors; Brooke Nichols; Urvi Parikh; Deenan Pillay; Tobias Rinke de Wit; Kim Sigaloff; Diane Havlir; Daniel R Kuritzkes; Anton Pozniak; David van de Vijver; Marco Vitoria; Mark A Wainberg; Elliot Raizes; Silvia Bertagnolio
Journal:  Lancet HIV       Date:  2017-11-22       Impact factor: 12.767

2.  Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.

Authors:  Rebecca Arden Harris; Jessica E Haberer; Nicholas Musinguzi; Kyong-Mi Chang; Clyde B Schechter; Chyke A Doubeni; Robert Gross
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

3.  Involvement, Perception, and Understanding as Determinants for Patient-Physician Relationship and Their Association with Adherence: A Questionnaire Survey among People Living with HIV and Antiretroviral Therapy in Austria.

Authors:  Helmut Beichler; Igor Grabovac; Birgit Leichsenring; Thomas Ernst Dorner
Journal:  Int J Environ Res Public Health       Date:  2022-08-19       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.